As of Nov 25
| +0.55 / +3.43%|
The 7 analysts offering 12-month price forecasts for Insmed Inc have a median target of 29.00, with a high estimate of 41.00 and a low estimate of 18.00. The median estimate represents a +74.80% increase from the last price of 16.59.
The current consensus among 7 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.